A Multiple Dose Study to Investigate the Effect of MK0859 on Lipoprotein Metabolism When Added to Ongoing Statin Therapy in Dyslipidemic Patients
Phase of Trial: Phase I
Latest Information Update: 16 Nov 2016
At a glance
- Drugs Anacetrapib (Primary) ; Atorvastatin
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Sponsors Merck & Co
- 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association
- 09 Sep 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 09 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.